Trulieve Cannabis Corp. Files 8-K

TL;DR

Trulieve filed an 8-K on Dec 8th, check it for updates.

AI Summary

Trulieve Cannabis Corp. filed an 8-K on December 9, 2025, reporting an event that occurred on December 8, 2025. The filing is categorized under 'Other Events' and includes 'Financial Statements and Exhibits'. Specific details regarding the nature of the event or any financial figures are not provided in this excerpt.

Why It Matters

This filing indicates a material event or change for Trulieve Cannabis Corp., requiring disclosure to investors and the public.

Risk Assessment

Risk Level: low — The filing itself is a standard disclosure document with no immediate indication of negative financial or operational impact.

Key Players & Entities

• Trulieve Cannabis Corp. (company) — Registrant
• December 8, 2025 (date) — Earliest Event Reported
• December 9, 2025 (date) — Filing Date
• 6749 Ben Bostic Road (location) — Principal Executive Offices Address
• Quincy, FL 32351 (location) — Principal Executive Offices City, State, Zip

FAQ

Key Financial Figures

• $100 million — Notes") for aggregate gross proceeds of $100 million (the "Offering"). The Notes, which will

Filing Documents

• tcnnf-20251208.htm (8-K) — 27KB
• exhibit991pressreleasedebt.htm (EX-99.1) — 11KB
• imagea.jpg (GRAPHIC) — 19KB
• 0001754195-25-000071.txt ( ) — 171KB
• tcnnf-20251208.xsd (EX-101.SCH) — 2KB
• tcnnf-20251208_lab.xml (EX-101.LAB) — 19KB
• tcnnf-20251208_pre.xml (EX-101.PRE) — 11KB
• tcnnf-20251208_htm.xml (XML) — 2KB

01 Other Events

Item 8.01 Other Events. On December 8, 2025, Trulieve Cannabis Corp. (the "Company") issued a news release announcing that it has received commitments for a private placement of 10.5% Senior Secured Notes due 2030 (the "Notes") for aggregate gross proceeds of $100 million (the "Offering"). The Notes, which will be issued at 100% of face value and will be senior secured obligations of the Company. The Notes will bear interest at a rate of 10.5% per annum, payable semi-annually in equal installments until the maturity date, unless earlier redeemed or repurchased. The Notes will mature on or about December 17, 2030, five years following the closing date of the offering, and may be redeemed in whole or in part, at any time from time to time, on or after the date that is two years following the issue date at the applicable redemption price set forth in the supplemental indenture to be entered into in connection with the closing of the Offering. The Company intends to use the net proceeds of the Offering for capital expenditures and other general corporate purposes. The offering and sale of the Notes have not been and will not be registered under the Securities Act of 1933, as amended (the "Securities Act"), or the laws of any other jurisdiction, and the Notes are being offered only (1) to persons reasonably believed to be qualified institutional buyers (as defined in Rule 144A) or to accredited investors (as defined in Rule 501 of Regulation D) in reliance on exemptions from the registration requirements under the Securities Act pursuant to Rule 506(b) of Regulation D and/or pursuant to Section 4(a)(2) of the Securities Act and similar exemptions under applicable U.S. state securities laws and (2) outside the United States to certain non-U.S. persons in reliance on Regulation S under the Securities Act. This Current Report on Form 8-K does not constitute an offer to sell, or the solicitation of an offer to buy, the Notes, and shall not constitute an offer, solici

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release dated December 8, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Trulieve Cannabis Corp. By: /s/ Eric Powers Name: Eric Powers Title: Chief Legal Officer Date: December 8, 2025

View Full Filing

View this 8-K filing on SEC EDGAR